Skip to main content
Premium Trial:

Request an Annual Quote

Orchid s 39-Percent Revenue Increase Leads to Narrowed Q3 Losses

NEW YORK, Oct. 26 (GenomeWeb News) - Orchid Biosciences reported an increase in revenues and narrowed losses in the third quarter, resulting in the first quarterly operating profit in the company's history, Orchid said today.


Orchid's revenues increased by 39 percent, to $16.4 million in Q3 2004, from $11.8 million for the year-ago period. Revenue growth was driven by increases in the company's forensics and scrapie susceptibility testing volumes, Qiagen said.


Orchid's net loss for the third quarter was $0.4 million, an improvement from $5.0 million for the third quarter last year. Orchid posted operating income of $176,000 and income of $383,000 from continuing operations before income taxes for the third quarter this year, marking the first quarterly operating profit in the company's history, it said.


As of Sept. 30, 2004, Orchid had $30.5 million in cash, cash equivalents, and short-term investments, of which $24.6 million were in cash and cash equivalents.


Separately, Orchid announced today that it has been selected by the Thames Valley Police as its exclusive provider of forensic DNA testing services.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.